1 March 2017 - President Donald Trump used his first address to a joint session of Congress on Tuesday to, among other things, promise to "slash the restraints" put on drug development by the Food and Drug Administration and across the government so the "slow and burdensome (drug) approval process" doesn't hinder medical advances.

To illustrate his point, he invited "miracles" like Megan Crowley to attend the speech.

Crowley is a 20-year-old sophomore at the University of Notre Dame who wasn't expected to live past age 5. She has Pompe disease, a serious and rare inherited disorder that leads to severe muscle weakness and heart problems. It is typically fatal. The disease had no pharmaceutical treatment until her father founded a company to develop an enzyme replacement therapy that would help save her life.

Read CNN article